Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Man Group PLC : Form 8.3 - RHI Magnesita N.V.
-
Man Group PLC : Form 8.3 - Vesuvius Plc
-
Man Group PLC : Form 8.3 - Sthree plc
-
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
-
MEXC and Payward Highlight Collaboration as Crypto and TradFi Converge at TOKEN2049
-
Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Transactions by persons discharging managerial responsibilities and persons closely associated with them
-
What is SGI: Centralized Super Intelligence Governance Platforms to Stop ‘Skynet Scare’ (Veterans First for America)
-
VenHub Highlights Continued Expansion of Intellectual Property Program
-
Chemtrade Logistics Income Fund Announces Plans for Conversion to A Simplified New Corporate Structure to Support Long Term Growth
-
Watsco Schedules Third Quarter Conference Call On Tuesday, October 27, 2026 at 10:00 a.m. (EDT)
-
King Copper Selects Drill Contractor for Inaugural Drill Program at Colquemayo
-
Aura Announces Preliminary Record High Production in Q3 2026 and 9M 2026 Production Results
-
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
-
Auction result of Treasury Bonds - RIKB 29 0416 - RIKB 38 0215
-
Women Legislators in 16 States Unite to Close ‘Voluntary Intoxication’ Loophole That Fails Sexual Assault Survivors
-
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
-
X4 Pharmaceuticals to Host Virtual Investor Day on Thursday, October 29, 2026, Featuring Key Opinion Leaders
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical D
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Aurora Mobile’s JPush Strengthens Shennong Group’s Messaging Infrastructure to Support Timely Delivery of Critical Business Information
-
Wrap Appoints Veteran Law Enforcement Leader John “Chappy” Chapman as Vice President of Training and Missions
-
Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermat
-
Overmatch Ventures announces first annual Austin Deep Tech 50
-
Manhattan Bridge Capital, Inc. Announces Increase and Extension of its Existing Buy-Back of up to 250,000 of its Common Shares
-
Stillwater Critical Minerals Corp. Begins Trading on OTCQX Best Market
-
Errington Metals Corp. Begins Trading on the OTCQX Best Market
-
Barrick to Report Third Quarter 2026 Results on November 9
-
Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026
-
Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanz
-
Inaugural Groundworks 2026 Summit Brings Industry Leaders to London to Scale Construction Robotics
-
Transaction in Own Shares
-
Inside information, profit warning: KH Group Plc specifies its guidance for 2026 and publishes preliminary net sales and comparable operating profit for the 3rd quarter. Comparable operating profit gr
-
Yacht Club de Monaco’s Tuiga wins at Saint-Tropez
-
OMODA & JAECOO’s September NEV Sales Reach 53,957 Units, Up 184% Year-on-Year, as Key European Markets Accelerate
-
OMODA & JAECOO’s September NEV Sales Reach 53,957 Units, Up 184% Year-on-Year, as Key European Markets Accelerate
-
Crypto News: Pepeto Announces Its DeFi Suite in Final Launch Steps While Ethereum Price Prediction Review Reaches $62,000
-
Viomi Technology Co., Ltd Announces Board Changes
-
Transocean Ltd. Announces Contract Backlog of Approximately $1.1 Billion, Including Fully Approved Equinor Agreement
-
K92 Mining Announces 2026 Third Quarter Financial Results Conference Call Details
-
MTY Reports Third Quarter Results For Fiscal 2026, Announces End of Strategic Review and Increases Dividend by 35%
-
WasabiCard Advances Global Partnership Discussions at TOKEN2049 and Shares Insights on APAC Payment Infrastructure
-
Form 8.3 - [GOOCH & HOUSEGO PLC - 08 10 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 08 10 2026] - (CGWL)
-
Form 8.3 - [POLLEN STREET GROUP LIMITED - 08 10 2026] - (CGAML)
-
Form 8.5 (EPT/RI)-Gooch & Housego plc
-
Form 8.5 (EPT/RI)- Gamma Communications Plc
-
T·Time Launches Cash-Pay Compounded GLP-1 and GIP Injections With Flat Pricing
